Product Features
-
- A three-line test that detects IgG, IgM & IgA to HIV-1, HIV-2 & T. pallidum
- Cost-effective screening tool by screening for two diseases in a single device
- Use serum, plasma or whole blood
- Results available within 15 minutes
Clinical performance:
-
HIV 1+2 Ab (comparing to a commercial rapid test)
-
Sensitivity: 100%
-
Specificity: 100%
-
Syphilis Ab (comparing to a commercial rapid test)
-
Sensitivity: 100%,
-
Specificity: 99%
-
Cross-Reactivity: no cross-reactivity found on 10 positive specimens from 13 disease states, such as dengue, HIV, HBV, HAV, T. pallidum, TB and others
-
No interference with some common substances, such as Bilirubin (20 mg/dL), Creatinine (442 µmol/L), EDTA (3.4 µmol/L), Glucose (55 mmol/L), Heparin (3,000 U/L), Human IgG (1,000 mg/L), Salicylic acid (4.34 mmol/L), Sodium citrate (3.8%)
Product specifications
- Individually sealed foil pouches containing:
- One cassette device
- One desiccant
- Plastic droppers
- Sample diluent (REF SB-R0035, 5 mL/bottle)
- Package insert (instruction for use)
Support
The OnSite HIV/Syphilis Ab Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies to HIV-1, HIV-2 and Treponema pallidum (Tp) in human serum, plasma or whole blood.
